Bioorganic & Medicinal Chemistry 2008-01-01

Characterization of the PON1 active site using modeling simulation, in relation to PON1 lactonase activity

Hagai Tavori, Soliman Khatib, Michael Aviram, Jacob Vaya, Hagai Tavori, Soliman Khatib, Michael Aviram, Jacob Vaya

Index: Bioorg. Med. Chem. 16 , 7504-9, (2008)

Full Text: HTML

Abstract

Paraoxonase1 (PON1) is a HDL bound enzyme and many of the anti-atherogenic properties of HDL are attributed to PON1. The enzyme precise mechanism of protective action and its endogenous substrate remain elusive. PON1 hydrolyzes organophosphates, arylesters and lactones, whereas the lactones activity is assumed as the physio/pathological one. This study is aimed to predict the location of the PON1 active site within PON1 crystal structure, and the lactone structure suitability as PON1 ligand, by employing modeling techniques. Based on such calculations the ligands-PON1 interactions were characterized, and relating lactones rate of hydrolysis revealed an inverse correlation with the docking energy of the ligands-PON1 complex, and a direct correlation with the lactone side chain length. In conclusion, this study characterized the PON1 possible active site and proposes a tool which may make it possible to envisage the structure of potential endogenous and exogenous lactones such as the PON1 ligand.


Related Compounds

Related Articles:

25-O-acetyl-23,24-dihydro-cucurbitacin F induces cell cycle G2/M arrest and apoptosis in human soft tissue sarcoma cells.

2015-04-22

[J. Ethnopharmacol. 164 , 265-72, (2015)]

Contrasting effects of W781V and W780V mutations in helix N of herpes simplex virus 1 and human cytomegalovirus DNA polymerases on antiviral drug susceptibility.

2015-04-01

[J. Virol. 89(8) , 4636-44, (2015)]

Identification and characterization of epithelial cells derived from human ovarian follicular fluid.

2015-01-01

[Stem Cell Res. Ther. 6 , 13, (2015)]

Matrix stiffening and β1 integrin drive subtype-specific fibroblast accumulation in lung cancer.

2015-01-01

[Mol. Cancer Res. 13(1) , 161-73, (2015)]

The HMGB1 protein sensitizes colon carcinoma cells to cell death triggered by pro-apoptotic agents.

2015-02-01

[Int. J. Oncol. 46(2) , 667-76, (2014)]

More Articles...